SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 and Rule 13a-17
or 15d-17 thereunder
MARQUEST MEDICAL PRODUCTS, INC.
----------------------------------------------------
(Exact name of issuer as specified in charter)
11039 East Lansing Circle, Englewood, Colorado 80112
----------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code: (303) 790-4835
--------------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more
in the number of shares outstanding
1. Title of Security Common Stock
----------------------------------------------------------
2. Number of shares outstanding before the change 8,246,880
----------------------------
3. Number of shares outstanding after the change 14,186,595
-----------------------------
4. Effective date of change March 28, 1996 - 3,877,859 shares, March 29,1996
--------------------------------------------------
- 2,061,856 shares
---------------------------------------------------------------------------
5. Method of change
Specify method (such as merger, acquisition, exchange, distribution,
stock split, reverse split, acquisition of stock for treasury, etc.)
Issuance of 3,877,859 shares upon conversion of debt and sale of
---------------------------------------------------------------------------
2,061,856 shares pursuant to private placement
---------------------------------------------------------------------------
Give brief description of transaction See above
------------------------------
- --------------------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change N/A
------------------------------------------------------
2. Name after change N/A
------------------------------------------------------
3. Effective date of charter amendment changing name N/A
-------------------------
4. Date of shareholder approval of change, if required N/A
-----------------------
Date March 29, 1996 /s/ William J. Thompson, President and
-------------------- ----------------------------------------
Chief Operating Officer
----------------------------------------
(Officer's signature and title)